| Surveillance of Tuberculosis
in Europe |
Tuberculosis cases
notified in 1995 |
2.
Feasibility Communication On average, three contacts per country were necessary
to obtain and verify the data. All communication tools were used:
telephone, fax, electronic mail and conventional mail. Communication
was difficult with some countries, particularly some Asian republics
of the former USSR. This may have hindered the validation of
information reported from these countries.
A national correspondent was identified in 49 of
the 50 countries of the WHO European region (98%). No contact
could be established in Ukraine.
Country participation
Forty eight countries sent data on tuberculosis cases
notified in 1995. Among these 48 countries, 19 (40%) provided
individual computerised data, 22 (46%) provided aggregate data,
five (10%) provided a total number of cases without further description
and two countries (4%), Georgia and Tajikistan, sent information
which either was too incomplete or could not be validated on
time. One country, Croatia, could not send data because of administrative
constraints.
After validation, a total number of tuberculosis
cases notified in 1995 was included for 46 countries, and data
from 41 countries were included in the overall description of
the cases.
Case definition
Among the 46 countries reporting a total number of
cases notified in 1995, 43 (93%) included all incident (new and
recurrent) definite and other than definite cases as recommended,
two (Greece and Kazakhstan) reported only the total number of
new cases, and one (Spain) reported only the total number of
new respiratory cases.
Among the 41 countries providing detailed information
on the characteristics of the cases, eight (19%) provided this
information on incident new cases only. Data for those countries
are presented separately. Through contacts with national correspondents
and by examining the data provided, it was observed that 15 of
these 41 countries (37%) did not report tuberculosis cases in
foreign citizens; of these, two also mentioned that prisoners
and military personnel were not included.
Data availability
Data availability was evaluated among the 41 countries
providing detailed information on notified cases:
- information on age was available as exact age
(in years) or according to recommended age groups in 33 countries
(80%) and according to different age groups in 7 countries
(17%). One country, Turkey, could not provide this information
for 1995.
- information on gender was available in all but
one country (Turkey).
- geographic origin of the patient was reported
by 21 countries (51%), of which eight reported the country
of birth, two reported the origin as born in the country
or abroad, six reported the country of citizenship and
five reported
the origin as national or foreign citizen. Among the
two latter groups, the Netherlands included Dutch patients
born abroad
to mothers of foreign origin in the category of "foreign
citizens", and Israel included foreign patients applying
for Israeli nationality in the category of "national citizens".
- new or recurrent status of the case was provided
by 34 countries (83%). Only a few countries provided the national
definition of a new and a recurrent case. Definitions were
not consistent across countries.
- site of disease was reported in 39 countries (95%):
13 provided the specific major site (among which 10 also provided
the minor site), 10 reported cases as pulmonary or extra-pulmonary,
and 16 reported cases as respiratory or extra-respiratory.
Information from the two remaining countries, Azerbaijan and
Turkmenistan, could not be included because of validation problems.
- bacteriological confirmation of the cases was
available in 34 countries (83%). The type of confirmation varied
across countries and was not necessarily dependent on the availability
of level II laboratories in the country : nine countries used
the positive culture (as recommended) and 25 used either positive
culture or positive sputum smear for defining a case as bacteriologically
confirmed.
- results of sputum smear examination were reported
by 27 countries (66%).
Completeness of individual information
Completeness of information was evaluated for the
19 countries providing individual computerised data.
In countries which provided variables describing
patient's characteristics, the proportion of missing values was
very low, with a maximum of 10% in France for the variable geographic
origin.
For variables describing the characteristics of the
disease :
- new or recurrent status of the case
In five countries (Denmark, France, Finland, Italy, Sweden), information
was missing for more than 10% (28% to 94%) of the cases. It was decided
to include information only for those countries with less than 30% of
the cases with unknown status.
- site of the disease
The proportion of missing values was very low for the major site, with a
maximum of 3% in Luxembourg. For the minor site, the proportion of missing
values was high (70% to 99%) in all 10 countries providing this variable.
However, this could reflect the absence of minor site as well as incomplete
information.
- bacteriological information
For the variables indicating whether bacteriological
examinations were performed, the proportion of missing
values varied across countries, ranging from
0% to 36% for the culture, and from 0% to 61% for the sputum smear
examination. Cases for whom it was not known whether
the examination had been done
may have been erroneously coded as "examination not done",
as suggested by the absence of missing values for these variables
in a few countries. In most countries, whether the examination
was done
for an individual patient was known only if a result (positive
or negative) was reported. Thus, the proportion of missing results
was 0% among cases
reported as having the examination performed in those countries
(12 of the 16 countries reporting sputum smear results, eight of
the 17 countries
reporting culture results). In some countries, only positive results
were reported: this reporting pattern was observed in Czech Republic
and France for the sputum smear examination, and in Denmark, Finland,
Luxembourg and Norway for the culture.
|